20 August 2004 19:25 [Source: ICIS news]
WASHINGTON (CNI)--The US Food and Drug Administration (FDA) said Friday that it will update its labeling requirements to reflect mounting evidence concerning the effect of antidepressants on suicidal tendencies in children.?xml:namespace>
FDA issued an analysis on the issue today. Medical researchers have accused the agency of acting slowly and ignoring multiple studies linking the drugs to suicidal tendencies in children and teens. British regulators have advised doctors to refrain from prescribing antidepressants to young people.
Despite an agreement between drug maker?xml:namespace>
An FDA advisory committee will discuss the latest findings at a public hearing on 13 September. Congressional committees also may call hearings next month to investigate the latest finding
The advisory committee meeting in September also will evaluate a recent
“While there are finding
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|